Effect of Anatabine on Elevated Blood Levels of C-reactive Protein

Completed · Not applicable

Conditions studied: Inflammation

In brief

The investigators are studying a dietary supplement called anatabine in a lozenge form named RCP006. The main purpose of this study is to evaluate the effects of this dietary supplement on normal human inflammatory function. The investigators will see this effect in volunteers who have markers of higher levels of inflammation to begin with. The investigators anticipate that anatabine will reduce markers of inflammation. Therefore the investigators are looking for volunteers with high blood levels of C-reactive Protein (CRP) and will monitor the blood CRP levels at several time points throughout the study.

Key facts

Study ID

NCT01607619

Run by

Roskamp Institute Inc.

People needed

117

Starts

2011-05-01

Expected to finish

2013-01-01

Last updated by the study team

2013-01-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• healthy adults with elevated blood levels of hsCRP

You may not qualify if…

• pregnancy or planning pregnancy
• current tobacco use
• current steroid use
• allergy to study product components

Where it is running

• The Roskamp Institute, Inc. — Sarasota, Florida, United States
• McLaren Community Medical Center — Flint, Michigan, United States
• Medical Practice — Shelby, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.